中海達(300177.SZ)擬定增募資不超9.8億元 投入社會治理平台項目等
格隆匯6月2日丨中海達(300177.SZ)發佈2020年非公開發行股票預案,本次非公開發行股票數量不超過1.98億股(含)。
本次非公開發行股票的發行對象不超過35名(含35名),為符合中國證監會規定的證券投資基金管理公司、證券公司、保險機構投資者、信託投資公司、財務公司、合格境外機構投資者,以及符合中國證監會規定的其他法人、自然人或其他合格的投資者。
公司本次非公開發行股票募集資金總額不超過9.80億元(含),在扣除發行費用後擬投入基於全要素網格的社會治理平台項目、基於時空智能技術的應急管理平台項目、高精度GNSS應用技術研發中心建設項目、補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.